The Times Australia
Google AI
Health

.

Pivotal Study Offers New Hope for Cognitive Health

  • Written by The Times

STUDY REVEALS ANTIOXIDANT UBIQUINOL PROVIDES SUPPORT FOR COGNITIVE HEALTH

411,100 Australians living with cognitive decline in 2023. Predicted to more than double by 2058, according to AIHWi

Powerful antioxidant Ubiquinol shown to support cognitive health

Lifestyle changes and supplementation in focus as antioxidant support provides hope for cognitive health

Researchers have provided a glimmer of hope for the tsunami of Australians suffering the symptoms of cognitive health challenges, as a pivotal study reveals that a daily dose of 100mg of Ubiquinolii may enhance cognitive health in older adults, supporting improvement in memory, attentiveness and work processing ability in middle-aged and elderly people.

This breakthrough research, published in The Japanese Journal of Pharmacology (2021) was conducted through a rigorous randomised, double-blind, placebo-controlled trial, underscoring the potential of Ubiquinol to support cognitive function which has been seen to be depleted due to age-related decline.

The study involved 90 adults aged between 50 and 83, monitored over a period of 34 weeks. Participants were administered a daily dose of 100mg of Kaneka Ubiquinol™, the patented bioidentical Ubiquinol ingredient made from a fermented yeast process. Cognitive performance was meticulously evaluated using established neuropsychological tests.

The findings showed that regular supplementation with Kaneka Ubiquinol™ led to improvements in cognitive function, particularly in the domains of memory, attention, and information processing. Additionally, Ubiquinol’s potent antioxidant properties played a crucial role in reducing oxidative stress, a major factor in cognitive decline and neurodegenerative diseases. By supporting mitochondrial health, Ubiquinol enhanced cellular energy production, which is vital for maintaining optimal brain health and function.

Gerald Quigley, Pharmacist and Master Herbalist said these world class findings continue to support the role of Ubiquinol in maintaining cognitive health, cardiovascular health and general wellbeing.

As we age, the decline in cognitive function including memory, recall and processing is impacted and for many people this a concern. It is promising that supplementation can provide an option for those looking to maintain their cognitive health and support brain function as they age.

This study which shows the antioxidant and mitochondrial support properties of Ubiquinol for cognition, provides an evidence-based supplementation option. It is pleasing that as healthcare professionals we can offer patients an option to help support their cognitive health and help address the growing challenge of cognitive decline in older adults.”

As the global population ages, maintaining cognitive health is becoming increasingly critical. Ubiquinol, supported by 90+ scientific studies and 80+ patents, is essential for cellular energy production and offers robust antioxidant support.

This research highlights Kaneka Ubiquinol™ as a vital ingredient for supporting brain health and providing defensive support for age-related cognitive decline.

RESEARCH HIGHLIGHTS:

Participants: 90 adults aged 50-83, monitored over 34 weeks.

Methods: In the randomised, double-blind, placebo-controlled trial, participants were administered 100mg of Kaneka Ubiquinol™ daily. Cognitive performance was assessed using standard neuropsychological tests.

Results: Significant improvements in cognitive function were observed. Measuring cognitive domains of processing speed, sequencing, mental flexibility and visual motor skills, Ubiquinol intake improved memory, attentiveness and work processing ability.

KEY FINDINGS:

  • Enhanced cognitive function: The study reveals that regular supplementation with Kaneka Ubiquinol™ can improve cognitive function in adults, particularly in areas related to memory, attention and information processing.

  • Reduced oxidative stress: Ubiquinol’s powerful antioxidant properties help reduce oxidative stress, a major factor in cognitive decline and neurodegenerative diseases.

  • Mitochondrial support: By supporting mitochondrial health, Ubiquinol enhances cellular energy production, crucial for maintaining brain health and function.

Always read the label and follow the directions for use. Consult your healthcare professional to determine if Ubiquinol is suitable for your needs.

ABOUT KANEKA UBIQUINOL™

Japan’s Kaneka Corporation is the global supplier of world-class scientifically formulated Ubiquinol, supported by 90+ scientific studies, 80+ patents and 45+ years of research for mitochondrial health, cardiovascular health, fertility and energy production. Now listed in over 50 countries in 500 Practitioner and OTC nutraceuticals brands. Kaneka Ubiquinol™ is the recipient of the Annual Ingredient Cardiovascular Health Award 2024 by Functional Foods for Wellness Summit (FFWS) and is Champion Ingredient for Alibaba 2023-2024. 

ii Kinoshita T, et al. The effects of ubiquinol (reduced form of coenzyme Q10) on memory, attentiveness, and work processing ability in healthy middle-aged and elderly residents – a randomized, double-blind, placebo-controlled trial. Jpn Pharmacol Ther 2021;49:1739-1747.

Times Magazine

Australia’s electric vehicle surge — EVs and hybrids hit record levels

Australians are increasingly embracing electric and hybrid cars, with 2025 shaping up as the str...

Tim Ayres on the AI rollout’s looming ‘bumps and glitches’

The federal government released its National AI Strategy[1] this week, confirming it has dropped...

Seven in Ten Australian Workers Say Employers Are Failing to Prepare Them for AI Future

As artificial intelligence (AI) accelerates across industries, a growing number of Australian work...

Mapping for Trucks: More Than Directions, It’s Optimisation

Daniel Antonello, General Manager Oceania, HERE Technologies At the end of June this year, Hampden ...

Can bigger-is-better ‘scaling laws’ keep AI improving forever? History says we can’t be too sure

OpenAI chief executive Sam Altman – perhaps the most prominent face of the artificial intellig...

A backlash against AI imagery in ads may have begun as brands promote ‘human-made’

In a wave of new ads, brands like Heineken, Polaroid and Cadbury have started hating on artifici...

The Times Features

Australia’s Coffee Culture Faces an Afternoon Rethink as New Research Reveals a Surprising Blind Spot

Australia’s celebrated coffee culture may be world‑class in the morning, but new research* sugge...

Reflections invests almost $1 million in Tumut River park to boost regional tourism

Reflections Holidays, the largest adventure holiday park group in New South Wales, has launched ...

Groundbreaking Trial: Fish Oil Slashes Heart Complications in Dialysis Patients

A significant development for patients undergoing dialysis for kidney failure—a group with an except...

Worried after sunscreen recalls? Here’s how to choose a safe one

Most of us know sunscreen is a key way[1] to protect areas of our skin not easily covered by c...

Buying a property soon? What predictions are out there for mortgage interest rates?

As Australians eye the property market, one of the biggest questions is where mortgage interest ...

Last-Minute Christmas Holiday Ideas for Sydney Families

Perfect escapes you can still book — without blowing the budget or travelling too far Christmas...

98 Lygon St Melbourne’s New Mediterranean Hideaway

Brunswick East has just picked up a serious summer upgrade. Neighbourhood favourite 98 Lygon St B...

How Australians can stay healthier for longer

Australians face a decade of poor health unless they close the gap between living longer and sta...

The Origin of Human Life — Is Intelligent Design Worth Taking Seriously?

For more than a century, the debate about how human life began has been framed as a binary: evol...